Tuesday, January 19, 2021
Tags Sinopharm

Tag: Sinopharm

Sinopharm Says Test Subjects for World’s First COVID-19 Inactivated Vaccine All Produced High Concentrations of Antibodies

Chinese state-owned pharmaceutical giant Sinopharm has hailed the success of trials of its COVID-19 inactivated vaccine, pointing to the production of high-concentrations...

Sinopharm Chairman Says COVID-19 Vaccine Has Proven Successful after Serving as Test Subject Himself

Sinopharm Group has hailed the safety and efficacy of a new COVID-19 vaccine after senior executives from the company served as trial...

Sinopharm Working on Coronavirus Vaccine, Officials Say Product Could Hit Market in Several Months

Chinese pharmaceutical giant Sinopharm Group Co., Ltd. says it's working on the development of a vaccine for the novel coronavirus, with domestic...

Most Read

Chinese Central Bank Hails Eradication of P2P Lending, “Orderly Disposal” of High-risk Financial Institutions

The People's Bank of China (PBOC) has highlighted the removal of all of the country's P2P lending platforms in 2020 as part...

NDRC Flags Active Fiscal Policy, Increased Spending on New Infrastructure in 2021

China's chief planning authority has outlined a raft of its policy intentions for 2021, as the national economy continues to recover from...

China’s GDP Breaches 100 Trillion Yuan Threshold after Posting 2.3% Growth in 2020, Disposable Income up 4.7%

Official data points to growth of over 2% in Chinese GDP in 2020 despite the adverse economic impacts of the COVID-19 pandemic....

China Bans Banks from Selling Depository Products via Third Party Online Platforms

Beijing has issued a new directive which further steps up pressure on the sale of depository products via online fintech platforms, after...